HF
BCLI

HRT Financial’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

HRT Financial’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,022
Closed -$45K – 2535
2024
Q4 		$45K Buy
+20,022
New +$37K ﹤0.01% 2122
2021
Q4 		– Sell
-5,433
Closed -$268K – 3198
2021
Q3 		$268K Sell
5,433
-300
-5% -$15.8K ﹤0.01% 2489
2021
Q2 		$326K Buy
+5,733
New +$306K ﹤0.01% 2091
2021
Q1 		– Sell
-1,775
Closed -$120K – 2698
2020
Q4 		$120K Buy
+1,775
New +$242K ﹤0.01% 1610

Other funds holding BCLI

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return